Osteoclasts differentiate from macrophage-lineage cells to become specialized for bone resorption function. By a proteomics approach, we found that Lyn was down-regulated by the osteoclast differentiation factor, receptor activator of NF-κB ligand (RANKL). The forced reduction of Lyn caused a striking increase in the RANKL-induced PLCγ1, Ca2+, and NFATc1 responses during differentiation. These data suggest that Lyn plays a negative role in osteoclastogenesis by interfering with the PLCγ1-mediated Ca2+ signaling that leads to NFATc1 activation. Consistent with the in vitro results, in vivo injection of Lyn specific siRNA into mice calvariae provoked a fulminant bone resorption. Our study provides the first evidence of the involvement of Lyn in the negative regulation of osteoclastogenesis by RANKL.
Bibliographical noteFunding Information:
This work was supported by 21C Frontier Functional Proteomics Project (FPR08B1-170), New Drug Target Discovery (M10748000257-07N4800-25710), and Science Research Center (R11-2008-023-01001-0) grants.
ASJC Scopus subject areas
- Structural Biology
- Molecular Biology
- Cell Biology